Late July 2026: Sika opens its largest U.S. mortar plant and acquires Akkim; IndexBox forecasts PCE demand to accelerate at 5.8% CAGR through 2035; Saint-Gobain signs definitive Xypex deal; U.S. cellulose ether prices rise 1.00% on tight Chinese supply.
Saint-Gobain’s Xypex acquisition plus the completed Fosroc close reshape the crystalline waterproofing map, US cellulose ether edges up 1.00% on Chinese export constraints, bio-based admixtures reach a regulatory inflection in Japan, Germany and California, and the global PCE industry passes 15 million tons of active capacity with low-alkali grades taking 60% share.
Mid-summer 2026 industry check-in: BASF closes its EUR 7.7B coatings divestment to refocus on construction chemistry, the Hassan et al. critical review ranks the four self-healing mechanisms in 3D-printed concrete, RDP demand stays Asia-led with bio-attributed VAE as the new differentiator, and the Thai TCMA mobile CCUS pilot plus India’s USD 2B budget test the limits of carbon-capture execution.
As the H2 2026 construction season opens, three structural forces are reshaping the construction chemicals industry: a demand recalibration across regions as CBAM definitive regime and divergent PMI readings sort winners from laggards; the maturation of bio-based PCE superplasticizers; and the rapid crystallization race in waterproofing admixtures. Here’s what buyers, formulators, and specifiers need to know.
LC3 cement reaches 35 commercial plants worldwide, PCE innovation advances with photo-initiated synthesis and phosphonate anchors, industry consolidation intensifies with Saint-Gobain EUR 6B combine and Sika CHF 180M synergies, Holcim CCUS enters execution phase targeting 1.1Mt CO2 capture, and cellulose ether pharma-grade premium accelerates with low-nitrosamine HPMC.
